It is a concern. We have a position that we support the collection of prescribing information but it should be de-identified of the prescriber as well as obviously the patient.
We hear some of those stories as well where it seems they get down to such a narrow postal code and there might only be two specialists so it's pretty obvious that these are the physicians who are prescribing. It is influencing the drug reps who are going in and talking to the physicians and the physicians are surprised that this much information is available.
It's really important that this information be collected to ensure that there's appropriate utilization of medications. What you have now are the representatives going in and they're prescribing usually their new products. There may be an equally effective and far less expensive generic product on the market that really should be used because it's been around longer and it has a lot more safety information about it, so you really don't want to have situations where that very targeted marketing and information is that widely available.
We certainly see that it's important to inform appropriate prescribing medication use and researchers to do that, but not for the marketing purposes that we hear about.